D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.2 MYR -2.44% Market Closed
Market Cap: 1.2B MYR
DPHARMA
/
Cash Flow Statement
/
Free Cash Flow

Duopharma Biotech Bhd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Free Cash Flow
myr64.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
14%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Free Cash Flow
myr1.7m
CAGR 3-Years
-32%
CAGR 5-Years
-31%
CAGR 10-Years
-3%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Free Cash Flow
-myr12m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Free Cash Flow
myr17.3m
CAGR 3-Years
155%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Free Cash Flow
myr40.6m
CAGR 3-Years
-12%
CAGR 5-Years
7%
CAGR 10-Years
23%
K
Kotra Industries Bhd
KLSE:KOTRA
Free Cash Flow
myr19.7m
CAGR 3-Years
-29%
CAGR 5-Years
-5%
CAGR 10-Years
0%

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.72 MYR
Undervaluation 30%
Intrinsic Value
Price
D
What is Intrinsic Value?

See Also

What is Duopharma Biotech Bhd's Free Cash Flow?
Free Cash Flow
64.2m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Free Cash Flow amounts to 64.2m MYR.

What is Duopharma Biotech Bhd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
14%

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.